Blood levels of sNfL, a neuron-specific cytoskeletal protein, have emerged as a biomarker able to capture neuronal damage in multiple sclerosis and a wide variety of neurological conditions.
Background. Serum neurofilament light chain (sNfL) is a biomarker of neuronal damage that is used not only to monitor disease activity and response to drugs and to prognosticate disease course in people with multiple sclerosis on the group level.
Click the image to learn more
====================
Stay informed with MS information, news and resources. Sign-up Here: https://bit.ly/3NkMIeR
Visit the MS Views and News articles and videos archives: https://wwwmsviewsandrelatednews.blog
Visit us on Facebook: www.facebook.com/msviewsandnews
Visit us on X (formally Twitter): www.twitter.com/MSViewsandNews
Visit us on Instagram: www.instagram.com/msviewsandnews
No comments:
Post a Comment
Thank You for leaving a comment.
Attempts to redirect viewers of this blog to another website and / or any marketing, will be removed.
Note: Only a member of this blog may post a comment.